ImClone and Bristol-Myers Squibb Announce ERBITUX Study Results
ImClone Systems and Bristol-Myers Squibb announced the results of several clinical studies of ERBITUX, an IgG1 monoclonal antibody, presented at…
network
ImClone Systems and Bristol-Myers Squibb announced the results of several clinical studies of ERBITUX, an IgG1 monoclonal antibody, presented at…
Corgentech, and Bristol-Myers Squibb Company announced top-line results from PREVENT IV, a Phase 3 clinical trial evaluating the use of…
Bristol-Myers Squibb Company is working with Yahoo to raise awareness of the global HIV/AIDS crisis through the "Light to Unite"…